Oxford, MS, and Montclair, NJ ― October 1, 2013 ― Mick Kolassa, Founding Partner at Medical Marketing Economics, has published an article on Michael Porter’s idea of the sustainable competitive advantage in business and the effects of that idea on the pharmaceutical industry in PM360 Online. “RIP Business Strategy Orthodoxy—and Good Riddance!” appeared in the September 2013 issue of the journal.
The complete article is available at the PM360 site.
For more information about PM360 as well as additional articles of interest, see the journal’s homepage.
For additional information about Mick Kolassa or Medical Marketing Economics, please contact us at 662.281.0502 or via e-mail at info@m2econ.com.
